BioSpace News Archive

Bavarian Nordic Assists Public Health England in Response to New Cases of Monkeypox

Bavarian Nordic A/S announced that the Company was recently engaged by Public Health England and the Medicines and Health Products Regulatory Agency to supply its IMVANEX® smallpox vaccine in response to new cases of monkeypox in the UK.

June 11, 2021
·
2 min read
British Columbia First Province to Cover Dexcom G6 Continuous Glucose Monitoring System for People With Type 1 and Type 2 Diabetes on Intensive Insulin Therapy

Dexcom, Inc. (NASDAQ: DXCM), a leader in real-time continuous glucose monitoring (CGM), announced today that people with diabetes who are on intensive insulin therapy, age two years or older, may now be eligible for provincial coverage of the Dexcom G6 CGM System through BC PharmaCare

June 11, 2021
·
4 min read
Business

ViewRay Announces Election of Karen N. Prange to its Board of Directors

ViewRay, Inc. (Nasdaq: VRAY) announced the election of Karen N. Prange to its Board of Directors by ViewRay’s stockholders at its 2021 Annual Meeting, effective today.

June 11, 2021
·
5 min read
FDA

Quidel Receives Amended Emergency Use Authorization for New Sofia® Q Rapid Antigen Test Device

Quidel Receives Amended Emergency Use Authorization for New Sofia ® Q Rapid Antigen Test Device

June 11, 2021
·
7 min read
BioCapital

COVID-19 Vaccine Drug Substance Manufactured by Emergent BioSolutions Authorized as Part of Johnson & Johnson’s Emergency Use Authorization

Emergent continues to work with the FDA to address identified observations at Bayview facility in order to release additional batches and resume production .

June 11, 2021
·
3 min read
BioCapital

Tetracore, Inc. Introduces First USDA-Licensed Real-Time PCR Test for the Detection of Foot and Mouth Disease Virus in Bovine, Swine and Ovine

Tetracore announced today the licensing of their VetAlert™ Foot and Mouth Disease Virus (FMDV) RNA Diagnostic Test Kit by the United States Department of Agriculture (USDA) Center for Veterinary Biologics (CVB).

June 11, 2021
·
2 min read
Drug Development

ImmVira completed the first dosing for Phase II of MVR-T3011 (intratumoral injection) in the U.S. and China

ImmVira announced that in the Phase II Clinical Trials of its leading oncolytic virus product, MVR-T3011* as intratumoral administration, ImmVira has completed the first dosing in both China and the U.S. on May 28 2021 and June 11 2021, respectively.

June 11, 2021
·
2 min read
Business

Vor Biopharma Names Matthew R. Patterson as Chairman and Promotes Tania Philipp

Vor Biopharma today announced Matthew R. Patterson as Chairman of its Board of Directors.

June 11, 2021
·
5 min read
Drug Development

Keros Therapeutics Presents Preclinical Data from ALK2 and KER-050 Hematology Programs at the European Hematology Association EHA2021 Virtual Congress

Keros Therapeutics today presented data from the ALK2 and KER-050 hematology programs at the European Hematology Association EHA2021 Virtual Congress held from June 9 through June 17, 2021.

June 11, 2021
·
12 min read
US Patent Office Grants Foundational Pharmacogenomic Patent

Genetic Technologies Limited, a diversified Genomics and AI driven preventative health business, has been granted US Patent No. 11,031,098 – ‘Computer Systems and Methods for Genomic Analysis’.

June 11, 2021
·
4 min read